申请人:AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY
ORGANISATION
公开号:EP2752415A1
公开(公告)日:2014-07-09
The invention provides fluorinated compounds of formula (I):
The compounds may be used in diagnosis or treatment of a disorder in a mammal characterised by an abnormal density of peripheral benzodiazepine receptors.
本发明提供了式 (I) 的含氟化合物:
这些化合物可用于诊断或治疗以外周苯并二氮杂卓受体密度异常为特征的哺乳动物疾病。